Financials

News Discussions Technicals Seasonals

ROQ fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

Roquefort Therapeutics Plc operates as an investment company. It was formed to acquire medical biotechnology businesses that are focused on early stage opportunities to include drug and vaccine development, diagnostics, immuno-therapy, and cell and gene therapies. The company was founded on August 17, 2020 and is headquartered in London, the United Kingdom.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends

ROQ has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company